Contrary to popular belief, curing a disease can be more economically valuable than relying on ongoing monthly treatments. Recent findings show that a one-time cure, achieving the same patient outcomes without recurring prescriptions, can offer over twice the financial return. Chief Futurist Brett Winton covers more on The Brainstorm.
|
The SpaceX S-1 dropped, and the $28 tril...
----------------------------------------...
Bloomberg's Mike McKee and Stuart Paul d...
Comprehensive cross-platform coverage of...
Bloomberg's Nacha Cattan joins Scarlet F...
On the early edition of Balance of Power...
Raymond Zeng lives in the San Francisco ...
----------------------------------------...
Goldman Sachs Vice Chairman Rob Kaplan, ...
Elon Musk’s rocket company, Space X, has...
America’s economy grew faster than that ...
Looking for the catalyst behind the sudd...
The SpaceX S-1 is finally here, and the ...
Looking for the explanation behind the m...
Looking for an update on the tech enterp...